EUVIMEDObjevte EUVIMED
VergleichsstudieKontrollierte klinische StudieKohortenstudieOpen access

Vertical Sleeve Gastrectomy Versus Comprehensive Lifestyle Intervention for Adolescents With Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Controlled Cohort Study

Toshifumi Yodoshi, Nicholas J Ollberding, Meghan McNeill, Sanita L Ley, Shelley Kirk, David E Kleiner iD, Ana Catalina Arce-Clachar, Kristin Bramlage, Thomas H Inge iD, Michael A Helmrath, Kim M Cecil, Andrew T Trout iD and 3 more

Alimentary Pharmacology & Therapeutics · 2026

DOI: 10.1111/apt.70766 ↗

At a glance

Vergleichsstudie in Alimentary Pharmacology & Therapeutics, 2026. Written by Toshifumi Yodoshi and 14 co-authors. Institution: Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. Major MEDLINE topics: Bariatric Surgery, Fatty Liver, Gastrectomy, Life Style. Cited 7 times so far (Crossref); 50 references. The full text is freely available in PubMed Central. Funded by: NIDDK NIH HHS, NIH HHS, National Institutes of Health.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Adolescents with severe obesity and metabolic dysfunction–associated steatotic liver disease (MASLD) lack prospective comparative evidence to select between bariatric surgery and intensive lifestyle intervention.

Aims

To compare 52‐week histological and cardiometabolic outcomes of vertical sleeve gastrectomy (VSG) versus comprehensive lifestyle intervention (CLI).

Methods

Single‐centre, prospective, parallel‐arm study of adolescents aged 12–19 with severe obesity and biopsy‐confirmed MASLD with NAFLD Activity Score (NAS) ≥ 3. The primary endpoint was NAS ≥ 2‐point decrease without fibrosis worsening; secondary endpoints included MASH resolution, fibrosis regression, MRI proton density fat fraction (MRI‐PDFF) and elastography (MRE). Overlap‐weighted adjusted analysis addressed baseline imbalance. Conservative unadjusted intention‐to‐treat analogue analyses treated missing Week 52 histology as nonresponse and missing continuous outcomes as no change.

Results

Forty‐two adolescents enrolled (VSG = 17; CLI = 25) and 27 (64%) completed paired Week 52 histology. In the adjusted analysis, VSG was associated with a higher probability of NAS improvement (risk difference [RD] 0.68, 95% CI 0.45–0.91), fibrosis improvement (RD 0.36, 95% CI 0.12–0.59) and complete MASLD resolution (RD 0.49, 95% CI 0.26–0.72) when compared to CLI. VSG produced greater reductions in percent weight (−19.6%, 95% CI −30.0 to −9.1), percentage of the 95th percentile BMI (−27.6%, 95% CI −42.6 to −12.7), ALT (−54.0 U/L, 95% CI −80.8 to −27.1) and MRI‐PDFF (−8.0%, 95% CI −13.0 to −2.9). Findings were directionally consistent in conservative unadjusted intention‐to‐treat and paired‐biopsy completer analyses.

Conclusion

In this prospective cohort of adolescents with severe obesity and biopsy‐confirmed MASLD, VSG achieved greater 52‐week histological improvement, including steatosis and fibrosis, than CLI. Trial Registration ClinicalTrials.gov identifier: (NCT02412540)

Subjects

MeSH terms (MEDLINE)

Bariatric SurgeryFatty LiverGastrectomyLife StyleNon-alcoholic Fatty Liver DiseaseObesity, MorbidAdolescentChildFemaleHumansMaleYoung AdultMagnetic Resonance ImagingProspective StudiesTreatment Outcome

Author keywords

metabolic dysfunction‐associated steatotic liver diseasepaediatric obesitysleeve gastrectomysteatohepatitis

Authors and institutions

  • Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Division of Gastroenterology, Hepatology, Pancreatology, and Nutrition, Stead Family Children's Hospital, Department of Pediatrics, University of Iowa, Iowa, USA.
  • Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Division of Nutrition Therapy, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

ORCID profiles: David E Kleiner, Thomas H Inge, Andrew T Trout, Deborah A Elder

Funding

  • NIDDK NIH HHS
  • NIH HHS
  • National Institutes of Health

Cite

APA

Yodoshi, T., Ollberding, N. J., McNeill, M., Ley, S. L., Kirk, S., Kleiner, D. E., Arce-Clachar, A. C., Bramlage, K., Inge, T. H., Helmrath, M. A., Cecil, K. M., Trout, A. T., Elder, D. A., Mouzaki, M., & Xanthakos, S. A. (2026). Vertical Sleeve Gastrectomy Versus Comprehensive Lifestyle Intervention for Adolescents With Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Controlled Cohort Study. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70766

Vancouver

Yodoshi T, Ollberding NJ, McNeill M, Ley SL, Kirk S, Kleiner DE, et al. Vertical Sleeve Gastrectomy Versus Comprehensive Lifestyle Intervention for Adolescents With Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Controlled Cohort Study. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.70766

BibTeX
@article{Yodoshi2026,
  author = {Yodoshi, Toshifumi and Ollberding, Nicholas J and McNeill, Meghan and Ley, Sanita L and Kirk, Shelley and Kleiner, David E and Arce-Clachar, Ana Catalina and Bramlage, Kristin and Inge, Thomas H and Helmrath, Michael A and Cecil, Kim M and Trout, Andrew T and Elder, Deborah A and Mouzaki, Marialena and Xanthakos, Stavra A},
  title = {Vertical Sleeve Gastrectomy Versus Comprehensive Lifestyle Intervention for Adolescents With Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Controlled Cohort Study},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1111/apt.70766}
}
Start for free →